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Article abstract—Objective: To compare the incidence rates for AD among elderly African-American, Caribbean His-
panic, and white individuals and to determine whether coincident cerebrovascular disease contributes to the inconsistency
in reported differences among ethnic groups. Methods: This was a population-based, longitudinal study over a 7-year
period in the Washington Heights and Inwood communities of New York City. Annual incidence rates for AD were
calculated and compared by ethnic group, and cumulative incidence adjusted for differences in education, diabetes,
cardiovascular risk factors, and stroke was calculated. Results: The age-specific incidence rate for probable and possible
AD was 1.3% (95% CI, 0.8 to 1.7) per person-year between the ages of 65 and 74 years, 4.0% (95% CI, 3.2 to 4.8) per
person-year between ages 75 and 84 years, and 7.9% (95% CI, 5.5 to 10.5) per person-year for ages 85 and older. Compared
to white individuals, the cumulative incidence of AD to age 90 years was increased twofold among African-American and
Caribbean Hispanic individuals. Adjustment for differences in number of years of education, illiteracy, or a history of
stroke, hypertension, heart disease, or diabetes did not change the disproportionate risks among the three ethnic groups.
Conclusion: The incidence rate for AD was significantly higher among African-American and Caribbean Hispanic elderly
individuals compared white individuals. The presence of clinically apparent cardiovascular or cerebrovascular disease did
not contribute to the increased risk of disease. Because the proportion of African-American and Caribbean Hispanic
individuals reaching ages 65 and older in the United States is increasing more rapidly than the proportion of white
individuals, it is imperative that this disparity in health among the elderly be understood.
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Prevalence and incidence rates for AD have been stud-
ied extensively throughout the world.1-20 Despite meth-
odologic differences in these studies, most have shown
a consistent rise in the frequency of AD with increasing
age. Women appear to have a higher frequency of AD
than men in some, but not all studies.17,19,21-23 Although
the prevalence and incidence rates for dementia in
Asia, China, Europe, and the United States are compa-
rable, the types of dementia can vary. For example, the
frequency of vascular dementia is reported to be higher
than that of AD among East Asians13 and Japanese-
Americans18 compared with most populations in the
United States and Europe.
Only a few studies in the United States have com-
pared the frequency of AD or other forms of demen-
tia among major ethnic groups. No differences in the
prevalence and incidence rates of AD were reported
among African-American and white individuals in
the Piedmont area of North Carolina participating in
the Duke Established Populations for Epidemiologic
Studies of the Elderly.5 However, Gurland et al.8 re-
ported a higher prevalence of all types of dementia,
including AD, among African-American and His-
panic individuals compared with white individuals in
northern Manhattan in a case registry and in a prob-
ability sample. In Houston, both prevalence and inci-
dence rates for AD were higher in African-American
and Hispanic retired municipal employees than in
white retirees.16 Two postmortem studies24,25 provide
conflicting results. Consecutive autopsies over an 18-
month period performed at the University of Michi-
gan Medical Center among individuals aged 65 years
and older revealed no differences in the frequency of
postmortem changes associated with AD among
African-American and white individuals.24 In con-
trast, a study in Baltimore25 found significantly more
pathologic changes consistent with AD pathology
among white individuals compared with African-
American individuals with or without a diagnosis of
dementia.
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It is unclear whether the conflicting results of
these studies are due to different methods of diagno-
sis and case ascertainment, or confounding factors
such as hypertension, stroke, or heart disease. Cross-
sectional studies cannot provide information con-
cerning the development of AD, and many previous
studies failed to carefully examine the contributions
of cardiovascular risk factors and stroke. The current
study provides new information comparing the inci-
dence rates of newly diagnosed AD over a 7-year
period from 1992 to 1999 in a community-based
study of African-American, Caribbean Hispanic, and
white elderly individuals residing in the communi-
ties of Washington Heights and Inwood in northern
Manhattan, New York City.8
Materials and methods. Subjects and setting. The co-
hort was identified from a probability sample of Medicare
beneficiaries residing in an area of three contiguous census
tracts in the northern Manhattan communities of Wash-
ington Heights and Inwood in New York City, an area from
151st Street North to 181st Street, bounded by the Hudson
and Harlem rivers. Access to the names of individuals was
provided by The Health Care Financing Administration
(HCFA). Before recruitment, each individual was sent a
joint letter explaining that they had been selected to par-
ticipate in a study of aging. The original HCFA list of 5,403
names was divided into six strata based on ethnic group
and age (65 to 74 years and 75 years and older). We used
HCFA data, supplemented by 1990 US Census files that
included a Hispanic surname list, to categorize ethnic
group. This allowed a tentative designation as African-
American (non-Hispanic), white (non Hispanic), and His-
panic. These strata were further divided into 37
representative subsamples so that the distributions by ethnic
group and age within each subsample would be similar. This
provided the means to ensure equal representation of the
community during the initial assessment of participants.
We determined that 896 (16.6%) of the original 5,403
individuals had moved from the region and that 470 (8.7%)
were dead. Another 409 (7.6%) could not be located despite
numerous attempts to contact them by telephone, regular
mail, and letters dropped off at the address provided by
HCFA. The proportion of individuals in each age strata not
located or found to be deceased was similar across the
three ethnic groups. An additional 176 (3.3%) were either
ineligible (younger than 65 years of age), did not reside in
the community during the baseline study period, or spoke
languages other than English or Spanish. One thousand,
three hundred twenty-four (25%) refused to participate in
the study. Excluding those who died, the proportion of
individuals in each age stratum that did not wish to partic-
ipate for any reason, including refusal, did not differ by
ethnic group. Two individuals were duplicated in the data-
base under different names. Data from 2,126 (62%) of the
3,452 eligible individuals were included in the baseline
assessment. Based on the distributions within the 37 sub-
samples, the proportion of individuals within each ethnic
group and age stratum who participated in the study did
not differ significantly from the source population.
The Columbia University Institutional Review Board
reviewed and approved this project. All individuals pro-
vided written informed consent.
Ethnic group. At the baseline interview, ethnic group
was confirmed by self-report using the format of the 1990
US Census.26 Briefly, each individual was first asked to
indicate his or her racial group, then asked whether or not
he was of “Hispanic” origin. Mixed category was not a
category in the 1990 US Census. This again confirmed the
separation into three groups: “black” (African-American,
non-Hispanic), “white” (non-Hispanic), or “Hispanic.” His-
panic individuals, therefore, could be either black or white.
For Hispanic individuals, we also asked for country of
birth or origin.
Clinical assessments. Detailed clinical assessments
were completed at approximately 24-month intervals over
the 7-year study period. All interviews were conducted in
either English or Spanish. The choice of language was
decided by the subject in order to ensure the best perfor-
mance, and the majority of assessments were performed in
the subject’s home. The maximum number of assessments
was four (baseline and three follow-up visits). Individuals
in the first four subsamples (12% of the cohort) underwent
a detailed general health interview that included a cogni-
tive test, the Care-Diagnostic Interview,27 and an assess-
ment of the ability to perform activities of daily life. A
standardized medical, neurologic, and neuropsychological
examination, which is described below, was also complet-
ed.28,29 In the remaining 33 subsamples, we used a two-
stage procedure. Based on the results from the first four
subsamples, we determined that the probability of demen-
tia among individuals with a Care-Diagnostic Interview
score below 3 was 6%. Therefore, only those subjects with a
Care-Diagnostic Interview score of 3 or higher and 25%
random sample of those who with scores below 3 under-
went the detailed examination described above in the first
four subsamples (n 5 1,072; 50.4%). However, for all
follow-up assessments, every subject, regardless of Care-
Diagnostic Interview score, received the complete clinical
examination described below.
The detailed clinical assessment included a standard-
ized medical and neurologic history and examination by a
trained physician. Medical diagnoses were assigned when
applicable and a tentative diagnosis of dementia, if deemed
appropriate, was made without benefit of neuropsychologi-
cal testing. This examination was repeated at each
follow-up visit.
The tests comprising the neuropsychological battery
were chosen because they represented several domains.
Orientation was tested using items from the modified
Mini-Mental State Examination.30 Language was exam-
ined using the Boston Naming Test,31 the Controlled Word
Association test,32 category naming, and the Complex Ide-
ational Material and Phrase Repetition subtests of the
Boston Diagnostic Aphasia Evaluation.33 Abstract Reason-
ing and Similarities subtests from the Wechsler Adult In-
telligence Scale–Revised34 and the nonverbal Similarities
subtest of the Mattis Dementia Rating Scale35 were used to
assess general reasoning ability. Visuospatial ability was
examined using the Rosen Drawing Test36 and a matching
version of the Benton Visual Retention Test.37 Memory was
evaluated using the multiple-choice version of the Benton
Visual Retention Test and the Selective Reminding Test.38
The time to complete the entire test battery ranged from
45 to 90 minutes.
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Results of the medical and neurologic examinations and
neuropsychological testing, including any tentative diag-
noses, were reviewed after each completed follow-up as-
sessment by a group of neurologists, psychiatrists, and
neuropsychologists, who reached consensus regarding the
presence or absence of dementia. Members of the consen-
sus group were blinded to information regarding ethnicity.
The reliability of this approach had been established earli-
er.28,39 Participants meeting criteria for dementia were fur-
ther subclassified according to published criteria for
probable and possible AD40 and vascular dementia.41 For
other types of dementia, we used a standardized protocol
for diagnosis (available upon request). Severity of demen-
tia for individuals with AD was rated using the Clinical
Dementia Rating Scale42 at the time of the consensus con-
ference. Individuals who performed within the normal
ranges for age and education previously established in the
community43 were considered unaffected at the date of that
assessment.
Data analysis. Age, ethnic group, and education level
were compared among those who did and did not develop
AD or another forms of dementia using x2 tests for categor-
ical variables, and analysis of variance and Student’s t-test
for continuous variables. To determine incidence rates, we
calculated the period from the baseline assessment to each
subsequent follow-up assessment for every individual.
Thus, all participants contributed to the total number of
person-years until they either became demented, died, or
were lost to follow-up. The incidence rate was calculated
by dividing the number of new cases (e.g., AD) by the total
number of person-years of follow-up. Incidence rates were
calculated within strata defined by age categories (65 to 74
years, 75 to 84 years, and 85 years and older), by years of
education (stratified by the median of 8 years), and by
ethnic group (as defined above). For the calculation of inci-
dence rates, we considered cases that met published critie-
ria40 only when they had a Clinical Dementia Rating
Scale42 score of 1.0 or higher for probable and possible AD.
Individuals with Clinical Dementia Rating Scale scores
below 1.0 were included as “unaffected.” We compared the
incidence rates between the ethnic groups by calculating
the standardized rate ratio with 95% CI, using white indi-
viduals as the referent group from which weights were
derived for the calculations.44
The Cox proportional hazard model45 was used to com-
pute the hazard ratio (HR) for AD. As has been recom-
mended for longitudinal investigations,46 the time to event
variable was age at onset of AD, requiring no further age
adjustment. Among those who did not develop AD, we
right-censored at the age at death, age at the last exami-
nation, or the age at which another form of dementia was
identified. Survival analysis was used to plot the cumula-
tive incidence of AD by age. Relative risks were calculated
for each ethnic group and adjusted by years of education
using white individuals as the referent group. Subsequent
proportional hazard models included the presence or ab-
sence of diabetes, hypertension, heart disease, or stroke in
order to estimate the HR adjusting for a history of cardio-
vascular or cerebrovascular disease by ethnic group. The
proportional hazards assumptions were evaluated using a
modified Martingale method.47
Results. Among the 2,126 participants, 327 (15.4%) were
demented at baseline. This left 1,799 without dementia
eligible for follow-up. In the cohort, 34.1% of individuals
identified themselves as African-American, 23.4% as
white, and 42.5% as Hispanic. The majority (84%) of those
identified as Hispanic were of Caribbean origin and 54%
were from the Dominican Republic. The remaining individ-
uals described as Hispanic were from Puerto Rico, Cuba,
Mexico, and Central America. Eleven individuals were
from a variety of other ethnic groups, and their data were
excluded from the analysis comparing ethnic groups, leav-
ing 1,788 participants. The demographic characteristics of
this follow-up cohort are shown in table 1. Similarities and
differences in the frequency of stroke, diabetes, hyperten-
sion, and heart disease are also shown in table 1. African-
American and Caribbean Hispanic elderly individuals
were slightly younger and less educated than white elderly
individuals. African-American individuals were slightly,








Age, y, mean (SD)* 75.8 (6.2) 74.9 (5.8) 76.9 (7.2)
Education, y, mean (SD)† 9.7 (3.5) 6.0 (4.1) 11.6 (4.1)
Women, % 71 68 65
Duration of follow-up, y, mean (SD) 4.3 (1.5) 4.4 (1.4) 4.3 (1.5)
History, %
Stroke 9.7 9.4 9.1
Diabetes‡ 18.7 22.1 10.3
Heart disease§ 25 33 29
Hypertension¶ 59 62 45
* p 5 0.001. White individuals were older than African-Americans and Caribbean Hispanics.
† p 5 0.001. White individuals had more years of education than either African-Americans or Caribbean Hispanics; African-Americans
had more years of education than Caribbean Hispanics.
‡ Diabetes was more frequent among African-Americans and Caribbean Hispanics than among white individuals.
§ p 5 0.01. Heart disease was more frequent among Caribbean Hispanics than African-Americans. Neither of these two groups differed
from white individuals.
¶ p 5 0.001. Hypertension was more frequent among African-Americans and Caribbean Hispanics than among white individuals.
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but significantly older and better educated than Caribbean
Hispanic individuals.
Diabetes and hypertension were more prevalent among
African-American and Caribbean Hispanic elderly individ-
uals than among white individuals (see table 1), but there
was no difference in the frequency of these disorders be-
tween these two groups. The frequency of heart disease
was higher among Caribbean Hispanic and white individ-
uals than among African-American individuals.
Probable or possible AD developed in 156 individuals
(8.7% overall; 130 probable, 26 possible), vascular demen-
tia in 36 (2.0%), and other dementia in 20 (1.1%) over the
entire follow-up period. Probable or possible AD occurred
significantly more frequently among African-American
(10.5%) and Hispanic (9.8%) individuals than in white
(5.4%) individuals (x2 5 10.5, df[2], p 5 0.03), but the
proportion of cases with probable or possible AD was simi-
lar within ethnic groups. The frequency of vascular demen-
tia was not different among African-American (2.6%) and
Hispanic (2.7%) individuals compared with white (1.0%)
individuals (x2 5 3.4, df[2], p 5 0.2). The frequency of
other dementias was also similar across the ethnic groups.
Losses due to death averaged 4.9% per year, losses due to
refusal to continue participation averaged 6.3% per year,
and losses to follow-up averaged 4.8% per year. None of
these rates differed by ethnic group nor did they vary by
study interval.
Incidence rates of AD. The age-specific incidence rate
for probable and possible AD was 1.3% (95% CI, 0.8 to 1.7)
per person-year between the ages of 65 and 74 years, 4.0%
(95% CI, 3.2 to 4.8) per person-year between ages 75 and
84 years, and 7.9% (95% CI, 5.5 to 10.5) per person-year
for ages 85 years and older. There were significant differ-
ences in the age-specific incidence rates for AD by ethnic
group (table 2; figure). The incidence rate among the 1,054
individuals who had received only the Care-Diagnostic In-
terview at baseline (all with scores below 3) was calculated
separately before including their data with the 1,072 that
received the entire assessment in the overall rates. The
age-specific incidence rates in these two groups did not differ
significantly from those in table 2.
Standardized rate ratios (SRR) were calculated to com-
pare the overall incidence rates of AD between the three
ethnic groups, using white individuals as the referent eth-
nic group. The age-specific incidence rates shown in table 2
for African-American and Hispanic individuals were
weighted by the proportion of person-years of follow-up for
white individuals. The overall crude incidence rate for
white individuals was 1.9% per person-year. The standard-
ized incidence rate for African-American individuals was
4.2% per person-year (SRR 5 2.2; 95% CI, 1.4 to 3.6). The
standardized incidence rate for Caribbean Hispanics was
3.8% per person-year (SRR 5 2.0; 95% CI, 1.2 to 3.2).
Thus, compared with white individuals in the same com-
munity, the incidence rates for African-American and Ca-
ribbean Hispanic individuals was increased twofold.
Figure. Annual age-specific incidence rates for AD among
African-American, Caribbean Hispanic, and white elderly
Medicare recipients in northern Manhattan. Black bars 5
white individuals; white bars 5 African-American indi-
viduals; striped bars 5 Caribbean Hispanic individuals.




at risk Incident AD
Incidence rate per
person-year, % 95% CI
65 to 74
African-American 778.74 13 1.7 0.7–2.6
Caribbean Hispanic 1,264.97 18 1.4 0.8–2.1
White 489.24 2 0.4 0.1–0.9
75 to 84
African-American 736.14 32 4.4 2.9–5.8
Caribbean Hispanic 937.15 42 4.4 3.1–5.8
White 494.93 13 2.6 1.2–4.0
85 and older
African-American 148.82 17 11.4 6.3–16.5
Caribbean Hispanic 137.09 12 8.8 4.0–13.5
White 165.89 7 4.2 1.1–7.3
65 and older
All groups 5,152.97 156 3.0 2.5–3.5
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We recalculated the incidence rates limiting the case
definition to probable AD (n 5 130) to decrease the possi-
bility that the higher rates among African-American and
Caribbean Hispanic individuals were due to comorbid ill-
ness, but the differences in incidence rates compared with
white individuals remained unchanged.
Age-specific incidence rates for vascular dementia over-
all varied from 0.47% (95% CI, 0.21 to 0.74) per person-
year between the ages of 65 and 74 years, 0.8% (95% CI,
0.45 to 1.2) per person-year between ages 75 and 84 years,
and 1.3% (95% CI, 0.27 to 2.3) per person-year for ages 85
and older. Because so few patients developed vascular de-
mentia, we did not attempt to compute the age-specific
incidence rates by ethnic group.
Cumulative incidence and relative risk. We compared
the cumulative risk of developing AD by ethnic group us-
ing Cox proportional hazards models adjusting for differ-
ences in education and potential confounding variables.
Compared with white individuals, the cumulative risk of
AD, adjusting for education, was significantly higher for
African-American and Caribbean Hispanic individuals (ta-
ble 3). In separate models, we recalculated the cumulative
risk adjusting for a history of diabetes, hypertension, and
heart disease among African-American and Hispanic indi-
viduals compared with white individuals, but the HR did
not change appreciably. A multivariate analysis including
simultaneous adjustments for hypertension, heart disease,
stroke, diabetes, and years of education also had minimal
effects on the HR (see table 3). We reanalyzed the main
effects, comparing cumulative risk in African-American
and Caribbean Hispanic individuals to that in white indi-
viduals by limiting the case definition to probable AD; the
results remained unchanged (African-Americans: HR 5
3.2, 1.7 to 5.9, p 5 0.001; Hispanics: HR 5 2.8, 1.5 to 5.3,
p 5 0.001). We repeated these analyses using a covariate
to indicate those individuals who had received the full
neuropsychological battery at the baseline assessment, but
the results were unchanged. An analysis including a co-
variate for illiteracy was completed, but the results did not
change.
Discussion. This community-based study, cover-
ing a period of 7 years, provided empirical evidence
indicating that the rate of newly acquired AD is sig-
nificantly higher among African-American and Ca-
ribbean Hispanic individuals than among white
individuals at similar ages. Differences in the inci-
dence rates were less pronounced for individuals be-
tween the ages of 75 and 84 years of age, but they
still remained significantly higher. These higher in-
cidence rates were independent of history of heart
disease, stroke, and risk factors for either cardiovas-
cular or cerebrovascular disorders. The differences in
incidence rates by ethnic group could not be attrib-
uted to variations in the level of education or to the
frequency of illiteracy, reducing the possibility that
there was a systematic error in diagnosis.
We have previously reported that the age-specific
prevalence of AD was higher in these two ethnic
groups compared with white individuals in the same
community.8 Prevalence is the proportion of affected
individuals at a specific point in time, and is an
estimate of the disease burden in the population.
Incidence rates reflect a more dynamic change in the
population because they indicate the number of
newly acquired cases developing among previously
healthy individuals. Cumulative incidence, or risk,
at specific ages should parallel the age-specific prev-
alence, and the figures reported here appear to be
consistent. Thus, not only is the relative proportion
of AD higher in these two ethnic groups compared
with white individuals, but the results of this study
indicate that the rate at which the disease is ac-
quired is also increased.
The results in white individuals in this commu-
nity are similar to those in studies from east Boston9
and Rotterdam.15 For example, in Rotterdam, the
age-specific incidence rates were approximately 0.3%
per person-year for persons between the ages of 65
and 74 years, 2.0% per person-year between ages 75
and 84 years, and 5.2% per person-year for persons
aged 85 years and older (see table 2 for comparison).
There has been considerable variation in the pub-
lished incidence rates for AD, but this has been at-
tributed to differences in the ways in which cases
were defined.3
Higher rates of AD among African-American indi-
viduals have been ascribed to comorbid cerebrovas-
cular diseases.6,12,25 The frequency of vascular
dementia was not significantly higher among
African-American and Caribbean Hispanic individu-
als compared to white individuals in this study, and
the rate we report is consistent with that of pub-
lished reports.21 The majority of individuals meeting
criteria for vascular dementia had appropriate brain
imaging studies confirming their diagnosis.48 The cu-
mulative risk of AD remained significantly higher
among African-American and Hispanic individuals
compared to white individuals after adjustment for
Table 3 Comparison of hazard ratios (HR) for probable and











22 (5.4) 1.0 (reference) 1.0 (reference)
Black
(n 5 610)
64 (10.5) 2.6 (1.6–4.2)† 2.4 (1.5–4.0)†
Caribbean Hispanic
(n 5 760)
70 (9.8) 2.3 (1.4–3.8)† 2.0 (1.2–3.4)‡




Heart disease 1.1 (0.8–1.6)
Hypertension 1.4 (0.9–1.9)
“AD” includes both probable and possible AD.
* Excludes 20 individuals who developed other forms of dementia
and 36 who developed vascular dementia.
†p # 0.001; ‡p # 0.01; §p # 0.05.
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the presence of stroke or history of diabetes, hyper-
tension, or heart disease. Therefore, neither clini-
cally apparent cardiovascular or cerebrovascular
disease contributed to the higher incidence rates of
AD in African-American and Caribbean Hispanic in-
dividuals compared to white individuals. Restricting
the analysis to probable AD, excluding comorbid ill-
nesses associated with stroke and cardiovascular dis-
ease, also did not change the results. Because we did
not have vascular imaging or electrocardiograms
available, we cannot exclude the possibility that indi-
viduals who developed AD may have had silent
strokes or subclinical cardiovascular disease.
Miller et al.24 studied consecutive autopsies over
an 18-month period between 1980 and 1982 at an
academic medical center in Michigan. They reported
no differences in the frequency of neuritic plaques
and neurofibrillary tangles, invariable pathologic
manifestations of AD, among African-American and
white patients, though no systematic clinical infor-
mation was available. However, de la Monte et al.25
reported that these same pathologic manifestations
of AD were more frequent in white individuals than
in African-American individuals among consecutive
autopsies in patients, regardless of whether the clin-
ical records indicated a history of dementia. They
also found significantly more cerebrovascular disease
among African-American individuals than among
white individuals, concluding that vascular dementia
was the most frequent cause of dementia in this
group. No clinical evaluations were performed in ei-
ther study, so clinicopathologic correlation could not
be performed. Postmortem studies such as these are
objective, but the lack of a detailed assessment of
clinical abilities during life makes interpretation dif-
ficult. Consent for autopsy also varies considerably
by ethnic group.49 Confidence in the clinical diag-
noses made in this study was buttressed by an ear-
lier report, in which we found the sensitivity and
specificity of the diagnosis of AD in this community
study to be high and not to vary by ethnic group.50
We previously reported that the risk of developing
AD was increased twofold among individuals with
less than 8 years of education or with low occupa-
tional attainment.51 In our analysis, adjusting or
stratifying by education as measured in years of
school attendance did not change the differences in
the frequency and cumulative risk of AD across eth-
nic groups. However, we could not fully explore the
interaction between education and ethnic group
membership in our study because the frequency of
white individuals with little to no education was very
low. There are inconsistent results relating AD risk
to level of education,19,23,51-57 suggesting that the level
of education may be a surrogate for other, as yet
unknown, exposures or experiences that occur early
in life.54 Clearly, the quantity and quality of educa-
tional experience can vary dramatically across ethnic
groups in the United States.58 Furthermore, adjust-
ing for illiteracy in the current study also did not
change the results.
Although the frequency of the APOE-e4 allele, a
major genetic risk factor for AD,59,60 is higher among
individuals in these two ethnic groups,61 we can not
attribute the increased frequency of disease to this
polymorphism. Compared to white individuals with-
out an APOE-e4 allele, the risk of AD among
African-American and Hispanic individuals was in-
creased by nearly threefold.62 Other allelic polymor-
phisms or gene mutations may contribute to the
higher rates of disease in these ethnic groups.63
Hispanic individuals represent a very large and
diverse cultural group around the world. Thus, our
results in Caribbean Hispanic individuals may not
generalize to all groups of Hispanics. The majority of
Caribbean Hispanic individuals in this community
study were from the Dominican Republic. Hispanics
from this country and other Caribbean nations may
share some of their genetic background with individ-
uals of African descent, which may partially explain
the similarity in disease risk.64-66 Because the propor-
tion of African-American and Hispanic individuals
living beyond age 65 years in the United States is
increasing more rapidly than the proportion of white
individuals,67 it is imperative that this disparity in
the rates of disease among the elderly be understood.
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Anatomic dissociation of auditory and
visual naming in the lateral
temporal cortex
Marla J. Hamberger, PhD; Robert R. Goodman, MD, PhD; Kenneth Perrine, PhD; and Tara Tamny, MA
Article abstract—Background and Objective: Visual object naming traditionally has been used to identify cortical areas
essential for naming (i.e., word retrieval), and investigators have found critical naming sites in the middle and posterior
temporal region in most patients. Based on clinical observation, empirical findings, and the pathophysiology of temporal
lobe epilepsy, the authors hypothesized that naming sites identified from auditory cues might also be relevant, and that
within the temporal region, these sites would be anatomically distinct and located anterior to naming sites based on visual
cues. Methods: Twenty patients requiring resective surgery involving the left (language dominant) temporal lobe under-
went pre-resection language mapping using direct cortical stimulation. Visual and auditory naming were tested at lateral
temporal sites extending from 1 cm from the anterior tip to the parietal operculum. Results: Auditory naming was
consistently disrupted by stimulation in the anterior temporal lobe, whereas both auditory and visual naming were
impaired by stimulation in the posterior temporal region. Conclusions: This pattern may explain why word finding
difficulties sometimes arise or worsen following surgical procedures in which the anterior temporal region is resected
without language mapping, or when resection is based on mapping that identifies language cortex exclusively using visual
tasks. These results suggest that utilization of auditory based naming tasks might improve pre-resection identification of
essential language cortex during direct stimulation cortical mapping, as well as noninvasive localization of dysfunction
during presurgical cognitive testing.
NEUROLOGY 2001;56:56–61
Stimulation-based cortical language mapping is of-
ten necessary in patients with intractable epilepsy
who are candidates for surgical resection within the
language dominant hemisphere. Lateral cortical
sites at which electrical stimulation impedes lan-
guage are considered essential for normal language
function and, therefore, are not included in the resec-
tion in order to preserve language postoperatively.
Although there is some variability in the particular
tasks employed during language mapping (e.g., nam-
ing, counting, reading),1 most investigators rely pri-
marily on visual object naming.2-5 This consists of
asking patients to name pictured items (e.g., bell,
escalator) during a brief electrical stimulus.2 The ra-
tionale for this approach is that visual object naming
is impaired in virtually all aphasic syndromes and,
therefore, preservation of cortex necessary for object
naming should reduce the probability of postopera-
tive aphasia.6 Results from investigations using ob-
ject naming tasks have been used to create “maps”
illustrating the cortical distribution of “essential”
language areas.3,7 Although there is considerable
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